AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Marathi's Potential in the Market and Competition with Amgen
The chapter discusses Marathi's market potential for G12C drugs and their combination program, as well as the comparison to Amgen's strategy. The speakers highlight Marathi's PRM-T5 program and the use of CVR for valuation. They also discuss Amgen's data on this drug class.